Collaboration, Licensing and Other Arrangements - Schedule of Revenue from Collaborations and Services (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Total revenue from collaborations and services	$ 51,253	$ 32,825	$ 140,490	$ 63,711
Collaborations and services
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Total revenue from collaborations and services	13,108	10,346	35,705	18,380
Collaborations and services | License and Distribution Agreement | Cipla Ltd
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Total revenue from collaborations and services	37	37	110	110
Collaborations and services | Co-Promotion Agreement | Vertice Pharma
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Total revenue from collaborations and services				325
Collaborations and services | Other
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Total revenue from collaborations and services				201
Collaborations and services | United Therapeutics Corporation | Commercial Supply Agreement
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Total revenue from collaborations and services	12,800	9,916	34,897	15,795
Collaborations and services | United Therapeutics Corporation | License Agreement
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Total revenue from collaborations and services	$ 271	$ 393	$ 698	$ 1,949